Edgewise Therapeutics (EWTX) vs Veradermics (MANE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Veradermics is the larger company by market cap ($4.64 billion vs $4.30 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EWTX | MANE |
|---|---|---|
| Share price | $39.57 | $110.95 |
| Market cap | $4.30B | $4.64B |
| 1-day change | -1.12% | +1.83% |
| YTD return | +59.46% | — |
| 1-year return | +161.36% | — |
| 5-year return | +123.06% | — |
| EPS (TTM) | $-1.84 | $-4.32 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-167.79M | $-70.00M |
| 52-week high | $48.51 | $131.24 |
| 52-week low | $14.25 | $32.00 |
| Distance from 52-week high | -18.43% | -15.46% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +32.98% | +47.36% |
| Average volume | 1.35M | 730.99K |
| Shares outstanding | 108.60M | 41.78M |
| Employees | 127 | 37 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Edgewise Therapeutics
EWTX stock →Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, sevasemten, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy.
Health Care · Biotechnology: Pharmaceutical Preparations · 127 employees
About Veradermics
MANE stock →Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children.
Health Care · Biotechnology: Pharmaceutical Preparations · 37 employees
EWTX vs MANE FAQ
Which is bigger, Edgewise Therapeutics or Veradermics?
Veradermics (MANE) is larger, with a market capitalization of $4.64B compared with $4.30B for Edgewise Therapeutics (EWTX).
Are Edgewise Therapeutics and Veradermics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.